253 related articles for article (PubMed ID: 15956757)
1. Coevolution of the relaxin-like peptides and their receptors.
Wilkinson TN; Speed TP; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():534-9. PubMed ID: 15956757
[TBL] [Abstract][Full Text] [Related]
2. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
3. Evolution of the signaling system in relaxin-family peptides.
Hsu SY; Semyonov J; Park JI; Chang CL
Ann N Y Acad Sci; 2005 May; 1041():520-9. PubMed ID: 15956755
[TBL] [Abstract][Full Text] [Related]
4. Receptors for relaxin family peptides.
Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
Ann N Y Acad Sci; 2005 May; 1041():61-76. PubMed ID: 15956688
[TBL] [Abstract][Full Text] [Related]
5. The evolution of the relaxin peptide family and their receptors.
Wilkinson TN; Bathgate RA
Adv Exp Med Biol; 2007; 612():1-13. PubMed ID: 18161477
[TBL] [Abstract][Full Text] [Related]
6. Membrane receptors: structure and function of the relaxin family peptide receptors.
Kong RC; Shilling PJ; Lobb DK; Gooley PR; Bathgate RA
Mol Cell Endocrinol; 2010 May; 320(1-2):1-15. PubMed ID: 20138959
[TBL] [Abstract][Full Text] [Related]
7. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7.
Liu C; Chen J; Kuei C; Sutton S; Nepomuceno D; Bonaventure P; Lovenberg TW
Mol Pharmacol; 2005 Jan; 67(1):231-40. PubMed ID: 15465925
[TBL] [Abstract][Full Text] [Related]
8. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
[TBL] [Abstract][Full Text] [Related]
9. Recent progress in relaxin-3-related research.
Liu C; Bonaventure P; Sutton SW; Chen J; Kuei C; Nepomuceno D; Lovenberg TW
Ann N Y Acad Sci; 2005 May; 1041():47-60. PubMed ID: 15956687
[TBL] [Abstract][Full Text] [Related]
10. Relaxin research in the postgenomic era.
Kawamura K; Sudo S; Kumagai J; Pisarska M; Hsu SY; Bathgate R; Wade J; Hsueh AJ
Ann N Y Acad Sci; 2005 May; 1041():1-7. PubMed ID: 15956679
[TBL] [Abstract][Full Text] [Related]
11. Identification of binding sites with differing affinity and potency for relaxin analogues on LGR7 and LGR8 receptors.
Halls ML; Bathgate RA; Sudo S; Kumagai J; Bond CP; Summers RJ
Ann N Y Acad Sci; 2005 May; 1041():17-21. PubMed ID: 15956682
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the rat INSL3 receptor.
Scott DJ; Fu P; Shen PJ; Gundlach A; Layfield S; Riesewijk A; Tomiyama H; Hutson JM; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():13-6. PubMed ID: 15956681
[TBL] [Abstract][Full Text] [Related]
13. Splice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexity.
Muda M; He C; Martini PG; Ferraro T; Layfield S; Taylor D; Chevrier C; Schweickhardt R; Kelton C; Ryan PL; Bathgate RA
Mol Hum Reprod; 2005 Aug; 11(8):591-600. PubMed ID: 16051677
[TBL] [Abstract][Full Text] [Related]
14. G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: further support that relaxin-3 is the physiological ligand for GPCR135.
Sutton SW; Bonaventure P; Kuei C; Nepomuceno D; Wu J; Zhu J; Lovenberg TW; Liu C
Neuroendocrinology; 2005; 82(3-4):139-50. PubMed ID: 16679775
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like factor 3: where are we now?
Ivell R; Hartung S; Anand-Ivell R
Ann N Y Acad Sci; 2005 May; 1041():486-96. PubMed ID: 15956750
[TBL] [Abstract][Full Text] [Related]
16. Relaxin family peptide receptors--from orphans to therapeutic targets.
van der Westhuizen ET; Halls ML; Samuel CS; Bathgate RA; Unemori EN; Sutton SW; Summers RJ
Drug Discov Today; 2008 Aug; 13(15-16):640-51. PubMed ID: 18675759
[TBL] [Abstract][Full Text] [Related]
17. Genetic targeting of relaxin and insl3 signaling in mice.
Feng S; Bogatcheva NV; Kamat AA; Agoulnik AI
Ann N Y Acad Sci; 2005 May; 1041():82-90. PubMed ID: 15956690
[TBL] [Abstract][Full Text] [Related]
18. Studies on soluble ectodomain proteins of relaxin (LGR7) and insulin 3 (LGR8) receptors.
Yan Y; Cai J; Fu P; Layfield S; Ferraro T; Kumagai J; Sudo S; Tang JG; Giannakis E; Tregear GW; Wade JD; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():35-9. PubMed ID: 15956685
[TBL] [Abstract][Full Text] [Related]
19. LGR7-truncate is a splice variant of the relaxin receptor LGR7 and is a relaxin antagonist in vitro.
Scott DJ; Tregear GW; Bathgate RA
Ann N Y Acad Sci; 2005 May; 1041():22-6. PubMed ID: 15956683
[TBL] [Abstract][Full Text] [Related]
20. Insulin-relaxin family peptide signaling and receptors in mouse brain membranes and neuronal cells.
Ortinau S; Lin F; Wade JD; Tregear GW; Bathgate RA; Gundlach AL
Ann N Y Acad Sci; 2005 May; 1041():211-5. PubMed ID: 15956710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
